# Secondary Prevention of Cardiovascular Disease in the Elderly Trial

> **NCT02596126** · PHASE3 · COMPLETED · sponsor: **Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III** · enrollment: 2499 (actual)

## Conditions studied

- Myocardial Infarction
- Cardiovascular Disease

## Interventions

- **DRUG:** Cardiovascular Polypill
- **DRUG:** Treatment Prevention for Secondary CV

## Key facts

- **NCT ID:** NCT02596126
- **Lead sponsor:** Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07
- **Primary completion:** 2021-10-31
- **Final completion:** 2022-03-31
- **Target enrollment:** 2499 (ACTUAL)
- **Last updated:** 2025-05-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02596126

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02596126, "Secondary Prevention of Cardiovascular Disease in the Elderly Trial". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02596126. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*